Association between rs4673 (C/T) and rs13306294 (A/G) haplotypes of NAD(P)H oxidase p22phox gene and severity of stenosis in coronary arteries

Gene

Volumn 499, Issue 1, 2012, Pages 213-217

  Najafi, Mohammad ^a   Alipoor, Behnam ^a   Shabani, Mohammad ^a   Amirfarhangi, Abdollah ^a   Ghasemi, Hassan ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Coronary artery; Haplotype; P22phox; Polymorphism; Rs13306294; Rs4673

Indexed keywords

REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE P22PHOX; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DISEASE SEVERITY; FEMALE; GENE FREQUENCY; GENE STRUCTURE; GENETIC ASSOCIATION; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; BASE SEQUENCE; CASE-CONTROL STUDIES; CORONARY STENOSIS; FEMALE; GENE FREQUENCY; GENETIC LINKAGE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NADPH OXIDASE; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; SEVERITY OF ILLNESS INDEX;

EID: 84859769448     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.02.032     Document Type: Article

References (33)

1. American Diabetes Association Standard of medical care in diabetes-2011. Diabetes Care 2011, 34:S11-S61.
2. Corsetti J.P., Ryan D., Moss A.J., Zareba W., Sparks C.E. NAD(P)H oxidase polymorphism (C242T) and high HDL cholesterol associate with recurrent coronary events in postinfarction patients. Atherosclerosis 2008, 196:461-468.
3. Di Castelnuovo A., et al. The C242T polymorphism of the p22phox component of NAD(P)H oxidase and vascular risk. Two case-control studies and a meta-analysis. Thromb. Haemost. 2008, 99:594-601.
4. Dinauer M.C., Pierce E.A., Bruns G.A., Curnutte J.T., Orkin S.H. Human neutrophil cytochrome b light chain (p22-phox). Gene structure, chromosomal location, and mutations in cytochrome-negative autosomal recessive chronic granulomatous disease. J. Clin. Invest. 1990, 86:1729-1737.
5. Doi K., Noiri E., Nakao A., Fujita T., Kobayashi S., Tokunaga K. Haplotype analysis of NAD(P)H oxidase p22 phox polymorphisms in end-stage renal disease. J. Hum. Genet. 2005, 50:641-647.
6. Fan M., et al. The p22phox C242T gene polymorphism is associated with a reduced risk of angiographically verified coronary artery disease in a high-risk Finnish Caucasian population. The Finnish Cardiovascular Study. Am. Heart J. 2006, 152:538-542.
7. Fang S., Wang L., Jia C. Association of p22phox gene C242T polymorphism with coronary artery disease: a meta-analysis. Thromb. Res. 2010, 125:e197-e201.
8. Glass C.K., Witztum J.L. Atherosclerosis: the road ahead. Cell 2001, 104:503-516.
9. Goliasch G., et al. The effect of p22-PHOX (CYBA) polymorphisms on premature coronary artery disease (≤40years of age). Thromb. Haemost. 2011, 105:529-534.
10. Heidari Y., Shah A.M., Gove C. NOX-2S is a new member of the NOX family of NADPH oxidases. Gene 2004, 335:133-140.
11. phox gene and ischemic cerebrovascular disease in the Japanese population. Stroke 2000, 31:936-939.
12. Kambayashi Y., et al. Efficient assay for total antioxidant capacity in human plasma using a 96-well microplate. J. Clin. Biochem. Nutr. 2009, 44:46-51.
13. Katsuyama M. Nox/NADPH oxidase, the superoxide-generating enzyme: its transcriptional regulation and physiological roles. J. Pharmacol. Sci. 2010, 114:134-146.
14. Kikuchi H., Hikage M., Miyashita H., Fukumoto M. NADPH oxidase subunit, gp91(phox) homologue, preferentially expressed in human colon epithelial cells. Gene 2000, 254(1-2):237-243.
15. Leto T.L., Morand S., Hurt D., Ueyama T. Targeting and regulation of reactive oxygen species generation by Nox family Nadph oxidases. Antioxid. Redox Signal. 2009, 11:2607-2619.
16. phox gene (-930A>G and +242C>T) and nephropathy as a result of type 2 diabetes in a Chinese population. Diabet. Med. 2006, 23:1037-1041.
17. Manea A. NADPH oxidase-derived reactive oxygen species: involvement in vascular physiology and pathology. Cell Tissue Res. 2010, 342:325-339.
18. phox C242T gene polymorphism in type 1 diabetes. Ann. N. Y. Acad. Sci. 2003, 1005:324-327.
19. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988, 16:1215.
20. Moreno M.U., San José G., Fortuño A., Beloqui O., Díez J., Zalba G. The C242T CYBA polymorphism of NADPH oxidase is associated with essential hypertension. J. Hypertens. 2006, 24:1299-1306.
21. Moreno M.U., et al. A novel CYBA variant, the -675A/T polymorphism, is associated with essential hypertension. J. Hypertens. 2007, 25:1620-1626.
22. Najafi M., Firoozrai M., Gohari H.L., Zavarehie A., Basiri G. Direct haplotyping of bi-allelic SNPs using ARMS and RFLP analysis techniques. Biomol. Eng. 2007, 24:609-612.
23. Najafi M., Roustazadeh A., Alipoor B. Ox-LDL particles: modified components, cellular uptake, biological roles and clinical assessments. Cardiovasc. Hematol. Disord. Drug Targets 2011, 11:119-128.
24. phox and catalase gene variants are associated with biomarkers of oxidative stress and adverse outcomes in acute renal failure. J. Am. Soc. Nephrol. 2007, 8:255-263.
25. Qin B., Yang H., Xiao B. Role of microRNAs in endothelial inflammation and senescence. Mol. Biol. Rep 2011, 10.1007/s11033-011-1241-0.
26. phox subunit is not associated with pre-eclampsia. J. Hum. Hypertens. 2002, 16:423-425.
27. Renner W., et al. C242T polymorphism of the p22 phox gene is not associated with peripheral arterial occlusive disease. Atherosclerosis 2000, 152:175-179.
28. San José G., Fortuño A., Beloqui O., Díez J., Zalba G. NADPH oxidase CYBA polymorphisms, oxidative stress and cardiovascular diseases. Clin. Sci. 2008, 114:173-182.
29. Stocker R., Keaney J.F. Role of oxidative modifications in atherosclerosis. Physiol. Rev. 2004, 84:1381-1478.
30. Sumimoto H. Structure, regulation and evolution of Nox-family NADPH oxidases that produce reactive oxigene species. FEBS J. 2008, 275:3249-3277.
31. Uenno N., Takeya R., Miyano K., Kikuchi H., Sumimoto H. The NADPH oxidase Nox3 constitutively produces superoxide in a p22phox-dependent manner: its regulation by oxidase organizers and activators. J. Biol. Chem. 2005, 280:23328-23339.
32. Xaplanteris P., et al. The effect of p22(phox) -930A/G, A640G and C242T polymorphisms of NADPH oxidase on peripheral and central pressures in healthy, normotensive individuals. Hypertens. Res. 2010, 33:814-818.
33. phox polymorphisms in patients with coronary artery disease. Antioxid. Redox Signal. 2002, 4:675-680.